The Prognostic Significance of Ploidy and DNA-Heterogeneity in the Primary Diagnosis and Monitoring of Patients with Locally Advanced Prostatic Carcinoma

REFERENCES

• Al-Abadi H, Nagel R. Zytomorphologische und DNS-zytophotometrische Aspekte bei der Behandlung des Prostatakarzinoms. Verband Dtsch Gesell Urol 1984; 36.
   Google Scholar
• Al-Abadi H, Nagel R. Prognostische Bedeutung von Ploidie und proliferativer Aktivität beim lokal fortgeschrittenen Prostatakarzinom. Akt Urol 1988; 4: 182–186.
   Google Scholar
• Al-Abadi H, Nagel R. Nuclear DNA Analysis: Relevance of ploidy, DNA heterogeneity and phases of the cell cycle. An 8-year study of 329 patients with prostatic carcinoma. Urol Int 1990; 45: 350–355.
   PubMedGoogle Scholar
• Al-Abadi H, Nagel R. Zellkern-DNS-Analyse bei Nierenkarzinomen unter Berücksichtigung des morphologischen Malignitätsgrades. Akt Urol 1987; 18: 137–141.
   Google Scholar
• Al-Abadi H, Nagel R. Prognostic Relevance of ploidy and proliferative activity of renal cell carcinoma. Eur Urol 1988; 15: 271–276.
   PubMedGoogle Scholar
• Atkin NB, Kay R. Prognostic significance of modal DNA value and other factors in malignant tumors, based on 1465 cases. Brit J Cancer 1979; 40: 210–221.
   PubMed Web of Science ®Google Scholar
• Auer G, Eriksson E, Azavedi E, Caspersson T, and Wall-gren A. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humane. Cancer Res 1984; 44: 394–396.
   PubMed Web of Science ®Google Scholar
• Baisch H, Otto U, König K, Klöppel G, Köllermann M, Linden WA. DNA content of human kidney carcinoma cells in relation to histological grading. Brit J Cancer 1982; 45: 878–886.
   PubMedGoogle Scholar
• Barlogie B, Göhde W, Johnston DA, Smallwood L, Schumann J, Drewinko B, Freireich EJ. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res 1978; 38: 3333.
   PubMed Web of Science ®Google Scholar
• Blöndahl T, Ponten J. DNA ploidy in small cell carcinoma of the lung. Anticancer Res 1983; 3: 47–52.
   PubMedGoogle Scholar
• Böcking A, Adler CP, Common HH, Hilgarth M, Grenzen B, Auffermann W. Algorithm for a DNA-cytopho-tometric diagnosis and grading of malignancy. Anal Quant Cytol 1984; 6: 1–8.
   PubMedGoogle Scholar
• Böhm N, Sandritter W. DNA in human tumors: A cytophotometric study. Springer, Berlin-Heidelberg-New York: Curr Top Pathol 1975; 60: 151.
   PubMedGoogle Scholar
• Borgmann V, Nagel R, Al-Abadi H, Schmidt-Gollwitzer M. Treatment of prostatic cancer with LH-RH analogues. The Prostate 1983; 4: 553–568.
   PubMed Web of Science ®Google Scholar
• Borgmann V, Al-Abadi H, Nagel R. Treatment of locally advanced prostatic carcinoma with LH-RH analogues: cytological, DNA-cytophotometrical and clinical results. Am J Clin Oncol (Supp. 1) 1988; 11: 19–28.
   Google Scholar
• Cox DE. Regression models and life tables. J Roy Stat Soc series B 1982; 34: 187.
   Google Scholar
• Feulgen R, Rossenbeck H. Mikroskopisch-chemischer Nachweis einer Nucleinsäure vom Typus der Thymonucleinsäure und die darauf beruhende elektive Färbung von Zellkernen in mikroskopischen Präparaten. Z Physiol Chem 1924; 135: 203–248.
   Google Scholar
• Franzén S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: A preliminary report. Br J Urol 1960; 32: 193–196.
   PubMedGoogle Scholar
• Friedlaender ML, Hedley DW, Tayler IW, Russell P, Coates AS, Tattersall MHN. Influence of cellular DNA contents on survival in advanced ovarian cancer. Cancer Res 1984; 44: 397–400.
   PubMedGoogle Scholar
• Gustafson H, Tribukait B, Esposti PL. DNA-profile and tumor progression in patients with superficial bladder tumors. Urol Res 1982; 10: 13–18.
   PubMedGoogle Scholar
• Helpap B, Böcking A, Dhom G, Faul P, Kastendieck H, Leistenschneider W, Müller HA. Klassifikation, histologisches und zytologisches Grading sowie Regres-sionsgrading des Prostatakarzinoms. Eine Empfehlung des Pathologisch-Urologischen Arbeitskreises ‘Prostatakarzinom’. Pathologie 1985; 6: 3–7.
   PubMedGoogle Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Stat Ass 1958; 53: 457.
   Web of Science ®Google Scholar
• Leistenschneider W, Nagel R. Einzelzellzytophotomet tische Zellkern-DNS-Analysen beim behandelten, entdifferenzierten Prostatakarzinom und ihre klinische Bedeutung. Urologie (A) 1983; 22: 157–161.
   PubMedGoogle Scholar
• Leistenschneider W, Nagel R. Estracyt-Therapie beim fortgeschrittenen Prostatakarzinom: Ergebnisse einer klinisch und zvtologisch kontrollierten Studie. Akt Urol 1983; 14: 127–131.
   Google Scholar
• Leuchtenberger C, Leuchtenberger R, Davis AM. A microspectrophotometric study of the desoxyribose nucleic acid (DNA) content in cells of normal and malignant human tissues. AmerJ Path 1954; 30: 65–85.
   PubMed Web of Science ®Google Scholar
• Mantel N. Ranking procedures for arbitrarily restricted observations. Biometrics 1967; 23: 65.
   PubMed Web of Science ®Google Scholar
• Raber M, Barlogie B, Farquhar D. Determination of ploidy abnormality and cell cycle distribution in human lung cancer using DNA flow cytometry. Proc Am Assoc Cancer Res 1980; 21: 40.
   Google Scholar
• Sandritter W. Methods and results in quantitative cytochemistry. In: Wied GL, Bahr GF, eds. Introduction to quantitative cytochemistry New York-London: Acad Press 1966; 159–182.
   Google Scholar
• Seppelt U, Sprenger E. Zellkern-DNS-Analysen durch Einzelzell-Fluoreszenz-Zytophotometrie an Prostata-karzinomen vor und während der Therapie. Verhandlungsbericht der Deutschen Gesellschaft für Urologie. 31. Tagung 1980; 68–72.
   Google Scholar
• Sprenger E. Kommentar zu den Arbeiten: Automatisierte Zellkernbestimmung und DNS-Analyse mit der Ein-zelzellphotometrie bei der Diagnostik des Prostatakarzinoms. Akt Urol 1979; 10: 359–360.
   Google Scholar
• Teodori L, Tirindell-Danesi D, Mauro F, de Vita R, Uccelli R, Botti C, Mondini C, Nervi C, Stipa S. Non-small cell lung carcinoma: Tumor characterization on the basis of flow-cytometrically determined cellular heterogeneity. Cytometry 1983; 4: 174–193.
   PubMedGoogle Scholar
• Tribukait B, Esposti P, Rönström L. Tumor ploidy for characterization of prostatic carcinoma: Flow-cytoflu-orometric DNA studies using aspiration biopsy material. Scand J Urol Nephrol, Suppl. 1980; 55: 59.
   PubMedGoogle Scholar
• Union International contre le Cancer: TNM Classification of malignant tumors. 3rd edition. International Union Against Cancer. Geneva 1978.
   Google Scholar
• Vindelov LL, Hansen HH, Christensen IJ, Spang-Thomsen M, Hirsch FR, Hansen M, Nissen MI. Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res 1980; 40: 4295–4300.
   PubMed Web of Science ®Google Scholar
• Wollev FR, Schreiber K, Koss LG, Karas M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behaviour. J Natl Cancer Inst 1982; 69: 15–22.
   PubMedGoogle Scholar
• Zetterberg A, Esposti PL. Cytophotometric DNA analysis of aspirated cells from prostatic carcinoma. Acta Cytol 1976; 20: 46.
   PubMedGoogle Scholar